[
  {
    "ts": null,
    "headline": "This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.",
    "summary": "Shares of  Zoetis  slumped Tuesday after the animal healthcare company reported weaker-than-expected quarterly revenue and slashed its full-year outlook.  The company posted adjusted earnings of $1.70 a share for the third quarter, above analysts’ consensus estimates of $1.62.  Zoetis  saw a particularly steep decline in revenue for its swine and poultry medicines.",
    "url": "https://finnhub.io/api/news?id=44eef593661e9e6d710442a34fa8b87e841a1bd84a960d0808b516f6bfbf7f59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762264740,
      "headline": "This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.",
      "id": 137312648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Shares of  Zoetis  slumped Tuesday after the animal healthcare company reported weaker-than-expected quarterly revenue and slashed its full-year outlook.  The company posted adjusted earnings of $1.70 a share for the third quarter, above analysts’ consensus estimates of $1.62.  Zoetis  saw a particularly steep decline in revenue for its swine and poultry medicines.",
      "url": "https://finnhub.io/api/news?id=44eef593661e9e6d710442a34fa8b87e841a1bd84a960d0808b516f6bfbf7f59"
    }
  },
  {
    "ts": null,
    "headline": "A Fresh Look at IDEXX Laboratories (IDXX) Valuation After Raising Full-Year Growth Outlook",
    "summary": "IDEXX Laboratories (IDXX) caught extra attention after releasing third-quarter results that showed healthy year-over-year gains in both revenue and net income. The company raised its full-year outlook, which signals ongoing growth. See our latest analysis for IDEXX Laboratories. Riding a wave of strong earnings and an upbeat full-year outlook, IDEXX Laboratories saw its share price surge nearly 15% in a single day and climb over 76% year-to-date. This performance has cemented its status as a...",
    "url": "https://finnhub.io/api/news?id=68766fbe01dce204d110ae48e742c36ed468c86e7610e52f74aff0e1d9730d65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762261973,
      "headline": "A Fresh Look at IDEXX Laboratories (IDXX) Valuation After Raising Full-Year Growth Outlook",
      "id": 137312758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories (IDXX) caught extra attention after releasing third-quarter results that showed healthy year-over-year gains in both revenue and net income. The company raised its full-year outlook, which signals ongoing growth. See our latest analysis for IDEXX Laboratories. Riding a wave of strong earnings and an upbeat full-year outlook, IDEXX Laboratories saw its share price surge nearly 15% in a single day and climb over 76% year-to-date. This performance has cemented its status as a...",
      "url": "https://finnhub.io/api/news?id=68766fbe01dce204d110ae48e742c36ed468c86e7610e52f74aff0e1d9730d65"
    }
  },
  {
    "ts": null,
    "headline": "Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum",
    "summary": "IDEXX Laboratories' stock narrative has seen a notable shift recently, as analysts update their outlook and raise the fair value price target from $679.92 to $702.17. This reflects growing confidence in business performance. This upward revision comes amid constructive sentiment around strengthening core revenue drivers and expanding opportunities in key markets. Stay tuned to find out how these changes could shape future perspectives and how you can keep informed on evolving analyst...",
    "url": "https://finnhub.io/api/news?id=601620ed5cc6e74d677251842d7df08412d00b64e96d3889ab43a9c5c1af194c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762258354,
      "headline": "Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum",
      "id": 137312759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories' stock narrative has seen a notable shift recently, as analysts update their outlook and raise the fair value price target from $679.92 to $702.17. This reflects growing confidence in business performance. This upward revision comes amid constructive sentiment around strengthening core revenue drivers and expanding opportunities in key markets. Stay tuned to find out how these changes could shape future perspectives and how you can keep informed on evolving analyst...",
      "url": "https://finnhub.io/api/news?id=601620ed5cc6e74d677251842d7df08412d00b64e96d3889ab43a9c5c1af194c"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Futures Drop as Fed Caution Weighs",
    "summary": "The Morning Bull - US Market Morning Update Tuesday, Nov, 4 2025 US stock futures are sliding premarket as investors digest hawkish signals from the Federal Reserve and ongoing signs of strain in the manufacturing sector. With Fed officials making it clear that a December rate cut is not guaranteed, and manufacturing data painting a mixed, uncertain picture, market sentiment is becoming more cautious as investors weigh the impact of elevated yields and weaker production on broader economic...",
    "url": "https://finnhub.io/api/news?id=4aa73b85898c9ebed210ed5ee658c5a25ca0f02152c761868b1aa54254eae944",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762251482,
      "headline": "S&P 500 Futures Drop as Fed Caution Weighs",
      "id": 137312760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "The Morning Bull - US Market Morning Update Tuesday, Nov, 4 2025 US stock futures are sliding premarket as investors digest hawkish signals from the Federal Reserve and ongoing signs of strain in the manufacturing sector. With Fed officials making it clear that a December rate cut is not guaranteed, and manufacturing data painting a mixed, uncertain picture, market sentiment is becoming more cautious as investors weigh the impact of elevated yields and weaker production on broader economic...",
      "url": "https://finnhub.io/api/news?id=4aa73b85898c9ebed210ed5ee658c5a25ca0f02152c761868b1aa54254eae944"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories (IDXX) Margin Beat Reinforces Premium Valuation Narrative",
    "summary": "IDEXX Laboratories (IDXX) posted a net profit margin of 24.4% for the latest period, up from 22.3% last year, and achieved earnings growth of 16.6% that outpaced its 5-year average of 10.3%. While revenue is forecast to grow at 8.2% per year and earnings at 9.2% per year, both figures trail the broader US market expectations of 10.5% and 16.1% respectively. Investors may be encouraged by the company’s improved profitability and consistent quality of earnings, even as forward growth is set to...",
    "url": "https://finnhub.io/api/news?id=f7db6623a4422dc024a3e342e403f003854c3805c46cc3240a30faade6f22e8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762247722,
      "headline": "IDEXX Laboratories (IDXX) Margin Beat Reinforces Premium Valuation Narrative",
      "id": 137312761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories (IDXX) posted a net profit margin of 24.4% for the latest period, up from 22.3% last year, and achieved earnings growth of 16.6% that outpaced its 5-year average of 10.3%. While revenue is forecast to grow at 8.2% per year and earnings at 9.2% per year, both figures trail the broader US market expectations of 10.5% and 16.1% respectively. Investors may be encouraged by the company’s improved profitability and consistent quality of earnings, even as forward growth is set to...",
      "url": "https://finnhub.io/api/news?id=f7db6623a4422dc024a3e342e403f003854c3805c46cc3240a30faade6f22e8c"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects",
    "summary": "Discover why IDEXX Laboratories (IDXX) outpaces the S&P 500 and offers strong long-term growth potential.",
    "url": "https://finnhub.io/api/news?id=ac16569df3d1650ab699d7a55c75bdcb698a941e599633bed22077fc76c13cbd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762234298,
      "headline": "IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects",
      "id": 137310872,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2218833097/image_2218833097.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "Discover why IDEXX Laboratories (IDXX) outpaces the S&P 500 and offers strong long-term growth potential.",
      "url": "https://finnhub.io/api/news?id=ac16569df3d1650ab699d7a55c75bdcb698a941e599633bed22077fc76c13cbd"
    }
  },
  {
    "ts": null,
    "headline": "Daily Market Wrap: Top Stocks - Amazon, Cipher, and Idexx Laboratories",
    "summary": "The first trading day of November began on an upbeat note but ended with a mixed finish, thanks to news on SNAP aid and the S&P 500 rallying after exceeding earnings reports in various sectors. The S&P 500 was up 0.2%, led by gains from numerous deals from Amazon.The tech-heavy Nasdaq ...",
    "url": "https://finnhub.io/api/news?id=1e93599eba08c0d32aee17763b97521929401b38863a27514d513b7f0aa2bd86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762224655,
      "headline": "Daily Market Wrap: Top Stocks - Amazon, Cipher, and Idexx Laboratories",
      "id": 137312196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "The first trading day of November began on an upbeat note but ended with a mixed finish, thanks to news on SNAP aid and the S&P 500 rallying after exceeding earnings reports in various sectors. The S&P 500 was up 0.2%, led by gains from numerous deals from Amazon.The tech-heavy Nasdaq ...",
      "url": "https://finnhub.io/api/news?id=1e93599eba08c0d32aee17763b97521929401b38863a27514d513b7f0aa2bd86"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Jumps 15% on Q3 Earnings Beat",
    "summary": "IDEXX Laboratories (NASDAQ: IDXX) extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations while raising full-year guidance. The stock was trading near $656 in early action after the pre-market announcement, holding steady as investors digested the results and prepared for the company’s earnings call at 8:30 ... IDEXX Laboratories Jumps 15% on Q3 Earnings Beat",
    "url": "https://finnhub.io/api/news?id=394571b22a47a14ed0e2acf0513f524997275d421b828033596c8d3b2a8289c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762215746,
      "headline": "IDEXX Laboratories Jumps 15% on Q3 Earnings Beat",
      "id": 137312763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories (NASDAQ: IDXX) extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations while raising full-year guidance. The stock was trading near $656 in early action after the pre-market announcement, holding steady as investors digested the results and prepared for the company’s earnings call at 8:30 ... IDEXX Laboratories Jumps 15% on Q3 Earnings Beat",
      "url": "https://finnhub.io/api/news?id=394571b22a47a14ed0e2acf0513f524997275d421b828033596c8d3b2a8289c9"
    }
  }
]